J-A35025-14

NON-PRECEDENTIAL DECISION - SEE SUPERIOR COURT I.O.P. 65.37 COMMONWEALTH OF PENNSYLVANIA, IN THE SUPERIOR COURT OF PENNSYLVANIA Appellee

v. PAMELA D. ATKINSON, Appellant No. 193 WDA 2014 Appeal from the Judgment of Sentence entered Decemb er 16, 2013,

in the Court of Common Pleas of Erie County, Criminal Division, at No(s): CP-25-CR-0002704-2012
BEFORE: BENDER, P.J.E., BOWES and ALLEN, JJ. MEMORANDUM BY ALLEN, J.: FILED JANUARY 05, 2015 Pamela D. Atkinson (“Appellant”) appeals from the judgment of sentence imposed after a jury convicted her of corr upt organizations, conspiracy to violate 18 Pa.C.S.A. § 911(b)(4), thr ee counts of possession of a controlled substance with intent to deliver (“PWI D”), and criminal use of a communication facility. 1 We affirm. The pertinent facts and procedural history may be summarized as follows: Following a grand jury investigation into the distribution of OxyContin and other controlled substances in Erie C ounty, Pennsylvania, Agent Alan McGill of the Office of Attorney General , Bureau of Narcotics Investigation and Drug Control learned that Appella nt was involved in a drug

____________________________________________ 1 18 Pa.C.S.A. §§ 911(b)(3), 903, 35 P.S. § 780-113( a)(3) and 18 P.S. § 7512(a).J-A35025-14

- 2 -

distribution ring. Affidavit of Probable Cause, 6/ 18/12. Utilizing a confidential informant named Ryan Fatica, Officer M cGill conducted controlled purchases of OxyContin from an individua l name Denise McConnell on July 7, 2010. Id .; N.T., 9/24/13, at 35-42. Ms. McConnell was thereafter arrested and informed the police tha t Appellant and a woman known only as “Viola” were her drug suppliers and t hat Appellant transported the drugs from New York to Erie approxi mately once a month. Affidavit of Probable Cause, 6/18/12. An investiga tion into Appellant’s medical records revealed that over several years, A ppellant had received numerous OxyContin prescriptions, with a value of a pproximately seventy thousand ($70,000.00) dollars, from a New York City physician. Id

. Appellant was subsequently arrested and charged wit h the aforementioned crimes. A jury trial commenced on September 24, 2013, at th e conclusion of which the jury rendered its convictions. Following a hearing on December 16, 2013, the trial court sentenced Appellant to an aggregate term of imprisonment of 48 to 124 months. Appellant filed a post-sentence motion on December 27, 2013, which the trial court denied by order entered on January 6, 2014. This timely appeal followed. The trial court did not direct Appellant to file a concise statement of errors com plained of on appeal pursuant to Pa.R.A.P. 1925. On February 5, 2014, t he trial court entered a memorandum opinion stating that the testimony given at trial, theJ-A35025-14

- 3 -

sentencing record, and the trial court’s January 6, 2014 order would suffice to address the issues raised on appeal. Appellant presents the following issues for our rev iew: 1. WHETHER THE EVIDENCE PRESENTED WAS INSUFFICIENT TO SHOW BEYOND A REASONABLE DOUBT THAT [APPELLANT] PERPETRATED, CONSPIRED TO COMMIT, OR ASSISTED WITH ANY OF THE CRIMES CHARGED HEREIN RELATED TO THE DELIVERY OF OXYCONTIN AS ALLEGED BY THE COMMONWEALTH?
2. DID THE TRIAL COURT COMMIT AN ABUSE OF DISCRETION AND/OR ERROR OF LAW WHEN IT ALLOWED THE COMMONWEALTH TO INTRODUCE CELL PHONE RECORDS, A DATABASE PRINTOUT FROM THE NATIONAL DRUG CODE DIRECTORY, AND PRESCRIPTION RECORDS, AS BUSINESS RECORDS UNDER PA.R.E. 803(6)? Appellant’s Brief at 4 In her first issue, Appellant argues that the evide nce was insufficient to support her convictions. Appellant’s Brief at 3 4-41. Our standard when reviewing the sufficiency of the evidence is whether the evidence at trial, and all reasonable inferences derived therefrom, when viewed in the li ght most favorable to the Commonwealth as verdict-winner, ar e sufficient to establish all elements of the offense beyond a r easonable doubt. We may not weigh the evidence or substitute our judgment for that of the fact-finder. Additionally , the evidence at trial need not preclude every possibility of inn ocence, and the fact-finder is free to resolve any doubts regarding a defendant's guilt unless the evidence is so weak and inconclusi ve that as a matter of law no probability of fact may be drawn f rom the combined circumstances. When evaluating the credib ility and weight of the evidence, the fact-finder is free to believe all, part or none of the evidence. For purposes of our revie w under these principles, we must review the entire record and co nsider all of the evidence introduced. Commonwealth v. Emler , 903 A.2d 1273, 1276–77 (Pa. Super. 2006).J-A35025-14

- 4 -

Appellant was charged with corrupt organizations ( 18 Pa.C.S.A. § 911(b)(3)), conspiracy to violate 18 Pa.C.S.A. § 91 1(b)(4), three counts of possession of a controlled substance with intent to deliver (35 P.S.. § 780- 113(a)(30)), and criminal use of a communication fa cility (18 P.S. § 7512(a)). With respect to Appellant’s conviction for the crim e of corrupt organizations, 18 Pa.C.S.A § 911(b)(3) provides: It shall be unlawful for any person employed by or associated with any enterprise to conduct or participate, dire ctly or indirectly, in the conduct of such enterprise's aff airs through a pattern of racketeering activity. To sustain a conviction for corrupt organizations, “the Commonwealth must prove that there was an ongoing organization e ngaged in commerce and that the associates of the organization functio ned as a continuing unit...” Commonwealth v. Donahue , 630 A.2d 1238, 1245 (Pa. Super. 1993). The statute further defines “pattern of rac keteering activity” as “a course of conduct requiring two or more acts of rac keteering activity one of which occurred after the effective date of this sec tion.” 18 Pa.C.S.A. § 911(h)(4). “Racketeering activity,” in turn, is de fined as, inter alia , “any violation of the Controlled Substance, Drug, Device and Cosmetic Act.” 18 Pa.C.S.A. § 911(h)(1)(ii). To sustain Appellant’s criminal conspiracy convicti on, the Commonwealth was required to establish that Appella nt: (1) entered into an agreement to commit or aid in an unlawful act with another person orJ-A35025-14

- 5 -

persons, (2) with a shared criminal intent, and (3) an overt act was done in furtherance of the conspiracy. Commonwealth v. McCall , 911 A.2d 992, 996 (Pa. Super. 2006). “This overt act need not be committed by the defendant; it need only be committed by a co-conspi rator.” Id (citations omitted). The essence of a criminal conspiracy is a common understanding, no matter how it came into being, th at a particular criminal objective be accomplished. The refore, a conviction for conspiracy requires proof of the exi stence of a shared criminal intent. An explicit or formal agre ement to commit crimes can seldom, if ever, be proved and it need not be, for proof of a criminal partnership is almost i nvariably extracted from the circumstances that attend its ac tivities. Thus, a conspiracy may be inferred where it is demo nstrated that the relation, conduct, or circumstances of the parties, and the overt acts of the co-conspirators sufficiently prove the formation of a criminal confederation. The conduct of the parties and the circumstances surrounding their con duct may create a web of evidence linking the accused to the alleged conspiracy beyond a reasonable doubt. Even if the conspirator did not act as a principal in committing the underl ying crime, he is still criminally liable for the actions of his c o-conspirators in furtherance of the conspiracy. Commonwealth v. Johnson , 719 A.2d 778, 784–85 (Pa. Super. 1998) (en banc). With respect to PWID, 35 P.S. § 780–113 provides: (a) The following acts and the causing thereof wit hin the Commonwealth are hereby prohibited:

... (30) Except as authorized by this act, the manufact ure, delivery, or possession with intent to manufacture or deliver, a controlled substance by a person not reg istered under this act, or a practitioner not registered or licensedJ-A35025-14

- 6 - by the appropriate State board, or knowingly creati ng, delivering or possessing with intent to deliver, a counterfeit controlled substance. Finally, in order to sustain Appellant’s conviction for criminal use of a communications facility, the Commonwealth was requi red to demonstrate: (1) Appellant knowingly and intentionally used a co mmunication facility; (2) Appellant knowingly, intentionally or recklessly fa cilitated an underlying felony; and (3) the underlying felony occurred. Commonwealth v. Moss , 852 A.2d 374, 382 (Pa. Super. 2004). “Facilitation has been defined as ‘any use of a communication facility that makes easier t he commission of the underlying felony.’ If the underlying felony never occurs, then [the defendant has] facilitated nothing and cannot be co nvicted under § 7512.” Id . (citations omitted). At trial, the Commonwealth presented the testimony of Ryan Fatica, who testified that he acted as a confidential infor mant for the police officers investigating OxyContin distribution in Erie. N.T. , 9/24/13, at 35-42. In his capacity as a confidential informant, on July 7, 20 10, he purchased 49 OxyContin pills from Denise McConnell, from whom he had obtained drugs in the past. Id

. The Commonwealth also presented the testimony of Ms . McConnell, who testified that she had regularly purchased OxyC ontin from Appellant over the course of three years. N.T., 9/25/13, at 8-14. Ms. McConnell testified that on July 7, 2010, after Mr. Fatica co ntacted her to requestJ-A35025-14

- 7 -

drugs, she spoke with Appellant over the phone to s et up the drug purchase, drove to Appellant’s house on East 22 nd Street, and was met there by a woman named “Vi” who provided Ms. McConnell with th e OxyContin that was subsequently delivered to Mr. Fatica. Id . Ms. McConnell testified that she had in the past participated in numerous drug trans actions with Appellant, where Ms. McConnell acted as the “middleman,” obtai ning drugs from Appellant to provide to various customers. Id . at 16-22. Additionally, the Commonwealth presented the testim ony of Jody Jefferson, who testified that he had purchased OxyC ontin from Appellant at her residence on East 22 nd Street. Id . at 56. The Commonwealth also presented the testimony of Vivian Schwindt, James W entz, and Jeremy Cook, who testified that although they never entere d Appellant’s residence at East 22 nd Street or dealt personally with Appellant, they re gularly accompanied Ms. McDonnell and/or Mr. Jefferson to t hat location to purchase drugs, and waited outside while Ms. McDonnell or Mr . Jefferson entered the residence and returned with OxyContin pills. Id . at 79-126. Additionally, Jill Valentino, an investigator from the New York State Department of Health, Bureau of Narcotic Enforcement, testified that her review of the New York State Department of health records revealed that Ox yContin in quantities of 300 units were dispensed to Appellant on 14 differe nt occasions between 2009 and 2011. Id . at 135-139. Moreover, the Commonwealth introduce dJ-A35025-14

- 8 -

telephone records revealing that on July 7, 2010, M s. McConnell placed calls to a telephone number which was listed to Appellant

. Id . at 162-165. We conclude that the foregoing evidence, when viewe d in the light most favorable to the Commonwealth as verdict winne r, was sufficient to support Appellant’s convictions for corrupt organiz ations, conspiracy, PWID and criminal use of a communication facility. Appellant asserts, nevertheless, that the evidence was insufficient to support her convictions because the Commonwealth pr esented evidence of only one actual drug delivery that occurred on July 7, 2010 between Ryan Fatica and Denise McConnell. Appellant’s Brief at 34-41. Appellant argues that that there was insufficient evidence to demons trate that she was physically present during the July 2, 2010 drug tra nsaction, and that given the lack of any testimony as to her involvement in any other specific drug transactions, the evidence was insufficient to supp ort any of her convictions. This claim is meritless because the jury could have reasonably concluded from the testimony that on July 7, 2010, Appellant sold Ms. McConnell the OxyContin that she later provided to Mr. Fatica; mo reover, the jury could have reasonably concluded, based on the testimony o f Ms. McConnell, Mr. Fatica and Mr. Jefferson, among others, that Appell ant regularly distributed OxyContin. Appellant next challenges the credibility of Mr. Fa tica, given that he described himself as a drug addict and pathological liar, and also challengesJ-A35025-14

- 9 -

the credibility of Ms. McConnell, Mr. Jefferson, Ms . Schwindt, Mr. Wentz, and Mr. Cook, on the basis that they were drug users, t hus rendering their testimony incredible. Id . However, it is well settled that the jury, as th e finder of fact, is free to believe all, part or non e of a witness’ testimony. Indeed, “[i]t is the function of the jury to evalua te evidence adduced at trial to reach a determination as to the facts.” Commonwealth v. G.Y. , 63 A.3d 259, 269-270 (Pa. Super. 2013). Here, even after A ppellant conducted a rigorous cross-examination of the Commonwealth’s wi tnesses designed to call into question their credibility and reveal wea knesses in their testimony, the jury, which was aware that the aforementioned w itnesses were drug users, nevertheless found their testimony persuasiv e. We will not disturb such credibility determinations on appeal. See Commonwealth v. Hudson , 414 A.2d 1381 (Pa. 1980) (holding that the fact t hat the witness used drugs and had a prior criminal record was a ma tter of credibility properly left to the jury's consideration). Appell ant’s sufficiency challenge fails. In her second issue, Appellant argues that the tria l court erred in permitting the Commonwealth to introduce evidence o f: (a) cell phone records, (b) a database printout from the National Drug Code Directory, and (c) prescription records from Express Scripts, as b usiness records under Pa.R.E. 803(6).J-A35025-14

- 10 -

“The admission of evidence is within the sound disc retion of the trial court and will be reversed only upon a showing that the trial court clearly abused its discretion.” Commonwealth v. Treiber , 874 A.2d 26, 31 (Pa. 2005). Here, Appellant first objects to the trial court’s decision to allow the Commonwealth to introduce evidence and testimony pe rtaining to AT&T and Sprint telephone records that revealed Appellant’s involvement in the July 7, 2010 drug transaction with Mr. Fatica and Ms. McDon nell. Specifically, at trial, the trial court permitted the Commonwealth t o present the testimony of Agent Robert Mattis, a narcotics agent with the Erie County Attorney General’s Technical Services Unit, who testified wi th regard to the aforementioned telephone records which he received after making an official request with the respective telephone companies. N .T., 9/25/13, at 143. Appellant argues that the telephone records constit uted hearsay that did not fall within any exception, and were therefore inadm issible because the Commonwealth failed to demonstrate that Agent Matti s was familiar with the record-keeping practices of AT&T and Sprint, and co uld not testify to whether the records were kept in the ordinary cours e of those businesses, in order for the records to be admissible under the bu siness records exception. Pa.R.E. 803(6), known as the ‘business record excep tion’ to hearsay, provides: The following are not excluded by the rule against hearsay, regardless of whether the declarant is available as a witness:J-A35025-14

- 11 -

(6) Records of a Regularly Conducted Activity. A record (which includes a memorandum, report, or data compilation in any form) of an act, event or condit ion if, (A) the record was made at or near the time by – or from information transmitted by – someone with knowledge; (B) the record was kept in the course of a regularly conducted activity of a “business”, which term includes business, institution, association, profession, occupation, and calling of every kind, whether or not conducted for profit; (C) making the record was a regular practice of that activity; (D) all these conditions are shown by the testimony of the custodian or another qualified witness, or by a certification that complies with Rule 902(11) or (1 2) or with a statute permitting certification; and (E) neither the source of information nor other circumstances indicate a lack of trustworthiness

The Uniform Business Records as Evidence Act, codif ied at 42 Pa.C.S.A. § 6108, additionally provides: A record of an act, condition or event shall, insof ar as relevant, be competent evidence if the custodian or other qua lified witness testifies to its identity and the mode of its prepa ration, and if it was made in the regular course of business at or ne ar the time of the act, condition or event, and if, in the opin ion of the tribunal, the sources of information, method and ti me of preparation were such as to justify its admission. 42 Pa.C.S.A. § 6108. Here, Agent Mattis testified that he was “very fami liar” with the way that telephone companies in general compile subscri ber telephone data.J-A35025-14

- 12 -

N.T., 9/25/13, at 144. Agent Mattis testified that “telecommunications providers [are] mandated by Congress to keep record s of customer usage and subscriber information relative to those client s so they’re available for law enforcement agencies upon valid requests that a re supported by court orders, subpoenas, and backed by affidavit of proba ble cause. Those are the records that they keep in the regular course of the ir business.” Id . He testified that every time a subscriber uses their c ell phone, “it would generate an electronic record that’s kept in a data base [and] upon the inquiry of law enforcement ... those records would then be compiled to a report, either paper or electronically, and then pr ovided to the requesting law enforcement agency.” Id . at 145. Moreover, at the time records were introduced, the Commonwealth presented documents en titled “Declarations of Authenticity” from the custodian of records at b oth Sprint and AT&T, attesting to the authenticity of the records. See Pa.R.E. 803(6)(D). Based on the foregoing, we find no abuse of discret ion in the trial court’s determination that Agent Mattis was a “qual ified witness.” See Pa.R.E. 803(D). In addition, the Commonwealth sepa rately verified the trustworthiness of the documents through “Declarati ons of Authenticity” signed by the record custodians at both AT&T and Sp rint attesting to their legitimacy. Id . We conclude therefore that the trial court did n ot err in permitting the Commonwealth to introduce evidence o f the telephone records. We are satisfied that the Commonwealth pr esented sufficient information to justify a presumption of the trustwo rthiness of the telephoneJ-A35025-14

- 13 -

records so as to offset the hearsay character of th e evidence. See Pa.R.E. 603(6)(E). Accordingly, Appellant’s challenge to t he admission of the evidence fails. Appellant next challenges the trial court’s decisio n to permit the Commonwealth to introduce a database printout from the National Drug Code Directory Website. The database printout was offered to rebut Appellant’s testimony that in April of 2010, Purdue Pharmaceutical Company (the manufacturer of OxyContin) ceased providing h er with “OxyContin OC ”, the version of Oxycontin she had previously been re ceiving. N.T., 9/26/13, at 58-62. Instead, Appellant claimed that after Ap ril 2010, she began to receive a new version of OxyContin labeled “OxyCont in OP ” which was gellike in form and could not be crushed or dissolved and therefore could not be abused, unlike the prior “ OC ” formulation. Id . By asserting that she last received “OxyContin OC ” in April 2010, Appellant sought to demonstrate that she could not have been involved in the July 7 , 2010 controlled buy involving Ms. McConnell and Mr. Fatica, in which po lice officers recovered 49 “OxyContin OC” pills. To rebut Appellant’s testimony that she no longer r eceived any “OxyContin OC ” pills after April 2010, the Commonwealth introduc ed the testimony of Agent Christopher Parker of the Erie C ounty Office of the Attorney General Diversion Investigative Unit, who testified, based on a printout from the “National Drug Code Directory” we bsite – which is generated by the United States Food and Drug Admini stration (FDA) – thatJ-A35025-14

- 14 -

“Oxycontin OP ” only became available for distribution on August 8, 2010. N.T., 9/26/13, at 133-140. Appellant argues that t he trial court erred in permitting the Commonwealth to introduce under the business records exception the information from the FDA’s online “Na tional Drug Code Directory” because Agent Parker was not qualified t o testify as to the business practices of the FDA and whether the FDA p repared and maintained the National Drug Code Directory in the regular cou rse of its business. Appellant’s Brief at 54-58. We conclude that even if the Commonwealth failed to lay an adequate foundation for the introduction of the National Dru g Code Directory printout as a business record, the trial court could have pr operly taken judicial notice of the FDA’s National Drug Code Directory as a sour ce “whose accuracy cannot reasonably be questioned.” See Pa.R.E., Rule 201(2) (“The court may judicially notice a fact that is not subject to reasonable dispute because it ... can be accurately and readily determined fro m sources whose accuracy cannot reasonably be questioned.”); 34 FR 11157 (Ju ly 1, 1969) (“The Secretary of Health, Education, and Welfare ... has directed the Commissioner of Food and Drugs to establish a Natio nal Drug Code System. The National Drug Code System will provide an ident ification system in computer language to permit automated processing of drug data by Government agencies, drug manufacturers and distrib utors, hospitals and insurance companies. The system has been developed with Governmentindustry agreement and will consist of a nine-chara cter National Drug CodeJ-A35025-14

- 15 -

(NDC)”); 36 FR 27; 21 U.S.C.A. § 360 (Registration of producers of drugs or devices). Accordingly, Appellant’s evidentiary cha llenge fails. Finally, Appellant challenges the trial court’s dec ision to permit the Commonwealth to introduce documentary evidence of A ppellant’s prescription records from Express Scripts, the phar macy that provided her with OxyContin. Appellant’s Brief at 58-59. Our r eview of the record reveals that when the Commonwealth introduced the Express S cripts prescriptions into evidence, Appellant did not object to their in troduction. N.T., 9/26/13, at 140-142. See Commonwealth v. Boyd , 679 A.2d 1284, 1289 (Pa. Super. 1996) (“In order to preserve for appellate r eview any claim of error regarding the admission of evidence, a party must s pecifically object to the admission of such evidence at trial. Failure to do so results in a waiver of that claim of error in the evidence's admission.”). This claim is therefore waived. For the foregoing reasons, we affirm the judgment o f sentence. Judgment of sentence affirmed.

Judgment Entered.

Joseph D. Seletyn, Esq. Prothonotary

Date: 1/5/2015J-A35025-14

- 16 -